Is stiripentol available in the USA? A Guide to Access and Prescribing
•
3 min read
In 2018, the U.S. Food and Drug Administration (FDA) approved stiripentol, marketed under the brand name Diacomit, for treating seizures associated with Dravet syndrome. This milestone confirmed that **is stiripentol available in the USA** for this specific, rare form of epilepsy.